Skip to content

Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies

Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03371316
Acronym
ViaShield
Enrollment
0
Registered
2017-12-13
Start date
2018-01-20
Completion date
2018-01-30
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemicraniectomies

Brief summary

The goal of this study is to demonstrate that ViaShield™ amnion patch is effective in preventing fibroblast activity and hence soft tissue adhesions after a hemicraniectomy.

Detailed description

A hemicraniectomy is a surgical procedure in which part of the skull is temporarily removed to relieve pressure on the underlying brain. Hemicraniectomies are typically performed on patients experiencing severe brain injury, usually due to stroke or trauma. In these cases, the brain injury and swelling is so severe that it can lead to brain compression and brain death. As a result, a surgeon will remove the bone flap to help with brain swelling and increased intracranial pressure. After the patient heals, a cranioplasty will be performed to restore the bone flap to its original location. When the central nervous system is deprived of its normal covering, as is the case with hemicraniectomies, the exposed area becomes the site of cellular reaction from surrounding tissue1 and soft tissue adhesions frequently develop between the skin flap and the dura mater or exposed brain, which may lead to less than optimal clinical outcome. ViaShield™ is an amnion patch produced from human amniotic membrane. Because of its inherent anti-adhesive properties, amnion serves as an ideal barrier against scarring and soft tissue adhesions to the neural elements, anterior vessels and hardware.

Interventions

BIOLOGICALViaShield

Anti-adhesion scores using amnion patch

Sponsors

Globus Medical Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All patients requiring a hemicraniectomy will also receive the amnion patch as an anti-adhesive barrier

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

18 years of age minimum Informed consent signed by patient or next of kin

Exclusion criteria

Immunosuppressive disorder

Design outcomes

Primary

MeasureTime frameDescription
Adhesion4-8 monthsAdhesion tenacity scores post hemicraniectomies 0 No adhesions 1. Thin membranous adhesions, no vessel attachment 2. Mild adhesions, blunt dissection required 3. Moderate adhesions, some sharp dissection required 4. Tenacious adhesions, sharp instrument dissection required, vessels attached The lower the score the better the outcome for the patient

Secondary

MeasureTime frameDescription
InfectionsFrom time of surgery to 8 months post-operativeWound Infections in or around hemicraniectomy site
hydrocephalusFrom time of surgery to 8 months post-operativeAccumulation of fluid around the brain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026